Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report

MLA

Rocío Maseda, et al. “Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.” Frontiers in Medicine, vol. 7, Nov. 2020. EBSCOhost, https://doi.org/10.3389/fmed.2020.576558.

APA

Rocío Maseda, Lucía Martínez-Santamaría, Rosa Sacedón, Nora Butta, María del Carmen de Arriba, Sara García-Barcenilla, Marta García, Nuria Illera, Isabel Pérez-Conde, Marta Carretero, Eva Jiménez, Gustavo Melen, Alberto M. Borobia, Víctor Jiménez-Yuste, Ángeles Vicente, Marcela del Río, Raúl de Lucas, & María José Escámez. (2020). Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.576558

Chicago

Rocío Maseda, Lucía Martínez-Santamaría, Rosa Sacedón, Nora Butta, María del Carmen de Arriba, Sara García-Barcenilla, Marta García, et al. 2020. “Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.” Frontiers in Medicine 7 (November). doi:10.3389/fmed.2020.576558.